1.42
4.41%
+0.06
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
23.95%
3.24
|
2.614 | 1.784 | 2.292 | 3.476 |
Interest Income/Expense |
-
|
- | - | - | - |
Operating Income/Loss |
23.95%
-3.24
|
-2.614 | -1.784 | -2.292 | -3.476 |
Nonoperating Income/Loss |
1.21%
0.167
|
0.165 | 0.185 | 0.124 | 0.137 |
Income/Loss From Continuing Operations Before Tax |
533.12%
-15.51
|
-2.449 | -1.599 | -2.168 | 3.339 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
533.12%
-15.51
|
-2.449 | -1.599 | -2.168 | 3.339 |
Net Income/Loss
|
533.12%
-15.51
|
-2.449 | -1.599 | -2.168 | 3.339 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-12.43
|
- | - | - | 6.678 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):